2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Two Brothers Creative
Category
Video - Promotion / Contest
Country / Region
United States
Entrant Company
ANDISITES INC>
Category
Website - Financial Services
Country / Region
United States
Entrant Company
LendingTree
Category
Website - Corporation
Country / Region
United States
Entrant Company
Accountable Healthcare Staffing
Category
Video - Animation
Country / Region
United States